Journey of Generic Imatinib: A Case Study in Oncology Drug Pricing

J Oncol Pract. 2017 Jun;13(6):352-355. doi: 10.1200/JOP.2016.019737. Epub 2017 Apr 26.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / economics*
  • Costs and Cost Analysis
  • Drugs, Generic / economics*
  • Imatinib Mesylate / economics*
  • Medical Oncology / economics
  • Protein Kinase Inhibitors / economics*

Substances

  • Antineoplastic Agents
  • Drugs, Generic
  • Protein Kinase Inhibitors
  • Imatinib Mesylate